Breakdown | |||||
TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
14.52B | 14.69B | 15.39B | 14.12B | 13.68B | 12.67B | Gross Profit |
924.00M | 928.00M | 1.03B | 807.00M | 826.00M | 592.00M | EBIT |
444.00M | 421.00M | 479.00M | 294.00M | 1.80B | 42.00M | EBITDA |
760.00M | 697.00M | 776.00M | 644.00M | 2.13B | 119.00M | Net Income Common Stockholders |
23.00M | 18.00M | 205.00M | -40.00M | 1.11B | -486.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
860.00M | 945.00M | 1.11B | 947.00M | 1.52B | 1.69B | Total Assets |
8.53B | 9.35B | 9.42B | 9.16B | 10.76B | 10.26B | Total Debt |
2.40B | 2.40B | 2.54B | 2.58B | 3.70B | 4.31B | Net Debt |
1.54B | 1.46B | 1.43B | 1.63B | 2.17B | 2.62B | Total Liabilities |
6.31B | 6.82B | 6.82B | 6.74B | 7.80B | 8.68B | Stockholders Equity |
1.88B | 2.13B | 2.23B | 2.07B | 2.38B | 1.21B |
Cash Flow | Free Cash Flow | ||||
331.00M | 277.00M | 415.00M | 47.00M | 0.00 | -80.00M | Operating Cash Flow |
606.00M | 543.00M | 667.00M | 274.00M | 260.00M | 246.00M | Investing Cash Flow |
-243.00M | -253.00M | -229.00M | 484.00M | 347.00M | 166.00M | Financing Cash Flow |
-444.00M | -497.00M | -271.00M | -1.27B | -770.00M | 393.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $14.26B | 11.04 | 15.52% | ― | -2.47% | -43.12% | |
79 Outperform | $2.25B | 7.82 | 25.15% | ― | -1.35% | -39.06% | |
76 Outperform | $7.10B | 25.97 | 5.38% | 1.36% | -8.22% | -52.61% | |
73 Outperform | $8.16B | 12.17 | 28.71% | 2.63% | -2.29% | 35.00% | |
73 Outperform | $4.67B | 10.24 | 10.00% | 3.48% | -3.15% | -6.70% | |
64 Neutral | $1.35B | 805.10 | -14.33% | ― | -5.33% | -292.58% | |
62 Neutral | $6.88B | 11.32 | 2.95% | 3.87% | 2.70% | -24.57% |
In May 2025, Adient representatives are scheduled to meet with investors to discuss the company’s business operations in China. The company has achieved significant growth in the past year, winning approximately $1 billion in new business and expanding its relationships with Chinese OEMs. Adient has also upgraded its technical center in Chongqing, enhancing its capabilities in electrification and smartification of auto seating technology. Despite challenging macroeconomic conditions, Adient continues to focus on profitable growth and maintaining strong financial performance.
The most recent analyst rating on (ADNT) stock is a Hold with a $24.00 price target. To see the full list of analyst forecasts on Adient stock, see the ADNT Stock Forecast page.
On March 11, 2025, Adient held its Annual General Meeting where shareholders elected eight directors for a one-year term, ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor, and approved the compensation of executive officers. Additionally, shareholders approved the adoption of an Amended Plan and renewed the Board’s authority to issue shares and opt-out of statutory preemption rights under Irish law, indicating strong support for the company’s governance and strategic initiatives.